Physician profile
William Wind
NPI 1932179736
$109,443.95
in general payments reported to CMS, 2019-2025
20 companies · $39K in 2025
The $39K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $361 · 2021: $19K · 2022: $14K · 2023: $5,438 · 2024: $19K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $52K · Travel and Lodging: $7,051 · Food and Beverage: $5,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $52,240.00 |
| Travel and Lodging | $7,051.41 |
| Food and Beverage | $5,027.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $96,010.58 | 2019-2025 | |
| Smith+Nephew, INC. | $6,724.34 | 2019-2025 | Healicoil, Bone Anchors With Arthroscopic Delivery System, Spatial Frame |
| Prodigy Surgical Distribution, INC. | $5,554.95 | 2019-2025 | |
| Stryker Corporation | $345.49 | 2023-2025 | Switchpoint Infinity, Isuite, Crossfire, 1688 |
| Ferring Pharmaceuticals INC. | $215.19 | 2019-2025 | Euflexxa |
| Pacira Therapeutics, INC. | $130.83 | 2019-2021 | |
| Fx Shoulder Solutions, INC | $125.15 | 2019 | |
| Bioventus LLC | $79.01 | 2023-2024 | Durolane, Exogen Ultrasound Bone Healing System |
| Lifenet Health | $61.44 | 2021 | |
| Axogen | $48.95 | 2023 | Avance Nerve Graft |
| Avanos Medical | $32.13 | 2022-2023 | Grpro 2.1 |
| Depuy Synthes Sales INC. | $23.54 | 2023 | Milagro, Dynacord, Truespan Orthocord |
| Dynasplint Systems INC. | $17.11 | 2024 | Dynasplint |
| Orthofix Medical, INC. | $15.43 | 2019 | |
| Kci USA, INC. | $14.41 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.37 | 2025 | Krystexxa |
| Djo, LLC | $12.23 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $11.71 | 2019 | |
| Heraeus Medical, LLC. | $7.09 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$220,811.37 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Wind listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.